There is mounting interest for researchers to start conducting studies with humans as soon as possible to find a vaccine and therapeutic treatments that are safe and effective, write Hastings Center research scholars Karen Maschke and Michael Gusmano, who also is an associate professor at Rutgers School of Public Health. The authors are “not eager to see Covid-19 interventions join the list of others that entered the clinic on the basis of limited or contested evidence of effectiveness and then harmed patients or proved to be ineffective. ” They suggest that effective strategies to minimize this risk require commitment from scientists, physicians, policymakers, patients, and the general public. To read the full article.
Recent Posts
- Join NJ ACTS on 2/12 at 4pm for the Pilots Program 2026 Webinar
- NJACTS Community Engagement Core Available Services
- Mental Health and Pain Medication Prescriptions for Young People Have Declined in the Past 20 Years.
- Researchers Pitch Strategies to Identify Potential Fraudulent Participants in Online Qualitative Research.
- Alzheimer’s Research Center Receives $1.5 Million to Launch Physician-Scientist Program.
Categories
- Community (2,438)
- Covid (996)
- CTO Events (6)
- News (3,087)
- Pilots (21)